Sponsor Pipeline

Shanghai Euhearing Therapeutics Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07288580 A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) Recruiting
Get alerts when Shanghai Euhearing Therapeutics Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free